To evaluate the effectiveness and usage patterns of Tofacitinib and bDMARD in a large real world cohort of Australian patients with Rheumatoid arthritis
Latest Information Update: 20 Jan 2022
At a glance
- Drugs Tofacitinib (Primary) ; Abatacept; Adalimumab; Anakinra; Certolizumab pegol; Etanercept; Golimumab; Infliximab; Rituximab; Tocilizumab
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
Most Recent Events
- 01 Jan 2022 Results of post-hoc analysis, assessing effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis, published in the Clinical Rheumatology
- 21 Jun 2019 New trial record
- 15 Jun 2019 Results presented at the 20th Annual Congress of the European League Against Rheumatism